Bain Capital Life Sciences Investors, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bain Capital Life Sciences Investors, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bain Capital Life Sciences Investors, LLC. Bain Capital Life Sciences Investors, LLC is 10% Owner in MARINUS PHARMACEUTICALS INC ($MRNS) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aptinyx Inc. ($APTX) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and 10% Owner in Arcutis Biotherapeutics, Inc. ($ARQT).
Latest Insider Trading Transactions of Bain Capital Life Sciences Investors, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANNX, APTX, ARQT, DRNA, MRNS, REPL, SWTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2021 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 71.50 | 1,450,000 | 103,675,000 | 5,831,307 | 7.3 M to 5.8 M (-19.91 %) |
| Oct 27 2020 | APTX | Aptinyx Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 3.00 | 3,333,333 | 9,999,999 | 8,891,758 | 5.6 M to 8.9 M (+59.97 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 2,812,543 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 22,222,221 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 17.00 | 400,000 | 6,800,000 | 3,241,628 | 2.8 M to 3.2 M (+14.08 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 319,243 | 0 | 2,841,628 | 2.5 M to 2.8 M (+12.66 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,522,385 | 0 | 2,522,385 | 0 to 2.5 M |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 2,825,602 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 17.00 | 294,117 | 4,999,989 | 3,979,292 | 3.7 M to 4 M (+7.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 859,573 | 0 | 3,685,175 | 2.8 M to 3.7 M (+30.42 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,825,602 | 0 | 2,825,602 | 0 to 2.8 M |
| Nov 21 2019 | DRNA | Dicerna Pharmaceut ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 22.03 | 1,750,000 | 38,552,500 | 5,580,237 | 7.3 M to 5.6 M (-23.87 %) |
| Sep 19 2019 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 1,053,204 | 0 | 0 | |
| Sep 19 2019 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 6,078,103 | 0 | 0 | |
| Sep 19 2019 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 18.00 | 150,000 | 2,700,000 | 7,281,307 | 7.1 M to 7.3 M (+2.10 %) |
| Sep 19 2019 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 1,053,204 | 0 | 7,131,307 | 6.1 M to 7.1 M (+17.33 %) |
| Sep 19 2019 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 6,078,103 | 0 | 6,078,103 | 0 to 6.1 M |
| May 31 2019 | DRNA | Dicerna Pharmaceut ... | Bain Capital Life Sciences Inv ... | Director | Sell | S | 12.50 | 1,600,000 | 20,000,000 | 7,330,237 | 8.9 M to 7.3 M (-17.92 %) |
| Jul 26 2018 | REPL | Replimune Group, I ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 235,146 | 0 | 0 | |
| Jul 26 2018 | REPL | Replimune Group, I ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 15.00 | 500,000 | 7,500,000 | 2,838,968 | 2.3 M to 2.8 M (+21.38 %) |
| Jul 26 2018 | REPL | Replimune Group, I ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,338,968 | 0 | 2,338,968 | 0 to 2.3 M |
| Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 7.11 | 55,229 | 392,430 | 3,977,453 | 4 M to 4 M (-1.37 %) |
| Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 7.62 | 94,771 | 722,240 | 4,032,682 | 4.1 M to 4 M (-2.30 %) |
| Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 7.50 | 300,000 | 2,251,440 | 4,127,453 | 4.4 M to 4.1 M (-6.78 %) |
| Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 8.64 | 102,882 | 888,489 | 4,427,453 | 4.5 M to 4.4 M (-2.27 %) |
| Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 8.02 | 719,665 | 5,770,202 | 4,530,335 | 5.3 M to 4.5 M (-13.71 %) |
| Dec 19 2017 | DRNA | Dicerna Pharmaceut ... | Bain Capital Life Sciences Inv ... | Director | Option Exercise | M | 0.00 | 250,000 | 0 | 0 | |
| Dec 19 2017 | DRNA | Dicerna Pharmaceut ... | Bain Capital Life Sciences Inv ... | Director | Grant | A | 0.00 | 190,849 | 0 | 8,930,237 | 8.7 M to 8.9 M (+2.18 %) |
| Dec 19 2017 | DRNA | Dicerna Pharmaceut ... | Bain Capital Life Sciences Inv ... | Director | Buy | M | 0.00 | 8,454,388 | 0 | 8,739,388 | 285 K to 8.7 M (+2,966.45 %) |
| Dec 19 2017 | DRNA | Dicerna Pharmaceut ... | Bain Capital Life Sciences Inv ... | Director | Buy | P | 7.00 | 285,000 | 1,995,000 | 285,000 | 0 to 285 K |
Page: 1